Organized by

Organizer Jungmin Choi (Korea University)
Chair Hong-Hee Won (Sungkyunkwan University), Jongbum Jeon (KOBIC)

This session will address recent advances in sequencing technologies, multi-omics integration, and AI-supported data analysis. Presentations will highlight practical considerations for population-scale genomics, emerging research applications, and examples of data interpretation enabled by analytic platforms. The session aims to provide researchers and clinicians with an overview of end-to-end genomic workflows and their potential impact on future precision medicine.

Organized by

Organizer Jaewhan Song (Yonsei University)
Chair Sang-Jun Ha (Yonsei University), Jeewon Sylvia Kim (SPARK at Stanford University)

The Yonsei University NRL 2.0 Bio-Centennial Convergence Institute will host a special session dedicated to translational research focused on aging and age-related diseases, showcasing a wide spectrum of innovative efforts aimed at bridging fundamental discoveries with clinical and commercial applications. This session will highlight cutting-edge research addressing the biological mechanisms of aging as well as therapeutic strategies targeting age-associated conditions such as cardiovascular diseases, metabolic syndromes, and cancer. Speakers will present diverse translational approaches, ranging from early-stage laboratory findings to preclinical development and clinical validation, illustrating how foundational science can evolve into impactful medical solutions.

In addition to scientific presentations, the program will include in-depth discussions on strategies for commercialization, intellectual property development, industry collaboration, regulatory pathways, and sustainable innovation models. Participants will explore practical frameworks for transforming academic discoveries into viable therapeutics, diagnostics, and biomedical technologies that address the growing global burden of aging populations.

A keynote lecture will be delivered by Professor Daria Mochly-Rosen of Stanford Medicine, Director of the Stanford SPARK program. She will share insights into the SPARK model, which has successfully accelerated the translation of university-based discoveries into real-world therapies and startup ventures. Her talk will provide a valuable perspective on building effective translational ecosystems, fostering academia–industry partnerships, and nurturing investigator-driven innovation.

This session is designed for researchers, clinicians, trainees, and innovators at all career stages who are interested in translational science. It will be particularly relevant to scientists seeking to connect basic research with practical implementation and commercialization. By fostering dialogue across disciplines and generations, the event aims to inspire a collaborative community committed to advancing discoveries in aging and age-related diseases into meaningful biomedical advances and societal impact.